{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:59:02Z","timestamp":1770703142188,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T00:00:00Z","timestamp":1451520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Dr. Robert Pfleger - Foundation","award":["#MSZ-DPF"],"award-info":[{"award-number":["#MSZ-DPF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11064-015-1765-0","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T05:01:51Z","timestamp":1451538111000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MH84: A Novel \u03b3-Secretase Modulator\/PPAR\u03b3 Agonist\u2014Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Maximilian","family":"Pohland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Hagl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Pellowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Wurglics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Schubert-Zsilavecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter P.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.clinthera.2015.05.510","volume":"37","author":"MJ Ehret","year":"2015","unstructured":"Ehret MJ, Chamberlin KW (2015) Current practices in the treatment of Alzheimer disease: where is the evidence after the phase III trials? Clin Ther 37:1604\u20131616","journal-title":"Clin Ther"},{"key":"1765_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14728214.2012.672559","volume":"17","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ (2012) Amyloid beta (A\u03b2) peptide modulators and other current treatment strategies for Alzheimer\u2019s disease (AD). Expert Opin Emerg Drugs 17:43\u201360","journal-title":"Expert Opin Emerg Drugs"},{"key":"1765_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cbpa.2009.04.619","volume":"13","author":"ML Bolognesi","year":"2009","unstructured":"Bolognesi ML, Matera R, Minarini A, Rosini M, Melchiorre C (2009) Alzheimer\u2019s disease: new approaches to drug discovery. Curr Opin Chem Biol 13:303\u2013308","journal-title":"Curr Opin Chem Biol"},{"key":"1765_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12035-012-8271-z","volume":"46","author":"GP Eckert","year":"2012","unstructured":"Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE (2012) Mitochondrial dysfunction\u2014a pharmacological target in Alzheimer\u2019s disease. Mol Neurobiol 46:136\u2013150","journal-title":"Mol Neurobiol"},{"key":"1765_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12035-010-8141-5","volume":"41","author":"WE M\u00fcller","year":"2010","unstructured":"M\u00fcller WE, Eckert A, Kurz C, Eckert GP, Leuner K (2010) Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer\u2019s disease\u2014therapeutic aspects. Mol Neurobiol 41:159\u2013171","journal-title":"Mol Neurobiol"},{"key":"1765_CR6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/ars.2007.1763","volume":"9","author":"K Leuner","year":"2007","unstructured":"Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, M\u00fcller WE (2007) Mitochondrial dysfunction: The first domino in brain aging and Alzheimer\u2019s disease? Antioxid Redox Signal 9:1659\u20131675","journal-title":"Antioxid Redox Signal"},{"key":"1765_CR7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM (2014) The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 1842:1219\u20131231","journal-title":"Biochim Biophys Acta"},{"key":"1765_CR8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Sch\u00fctt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Dr\u00f6se S, Wittig I, Willem M, Haass C, Reichert AS, M\u00fcller WE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16:1421\u20131433","journal-title":"Antioxid Redox Signal"},{"key":"1765_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2011-101356","volume":"25","author":"L Katsouri","year":"2014","unstructured":"Katsouri L, Parr C, Bogdanovic N, Willem M, Sastre M (2014) PPAR\u03b3 co-activator-1\u03b1 (PGC-1\u03b1) reduces amyloid-\u03b2 generation through a PPAR\u03b3-dependent mechanism. J Alzheimers Dis 25:151\u2013162","journal-title":"J Alzheimers Dis"},{"key":"1765_CR10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.0503839103","volume":"103","author":"M Sastre","year":"2006","unstructured":"Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, Borghgraef P, Evert BO, Dumitrescu-Ozimek L, Thal DR, Landreth G, Walter J, Klockgether T, van Leuven F, Heneka MT (2006) Nonsteroidal anti-inflammatory drugs repress \u03b2-secretase gene promoter activity by the activation of PPAR\u03b3. Proc Natl Acad Sci USA 103:443\u2013448","journal-title":"Proc Natl Acad Sci USA"},{"key":"1765_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2006.06.001","volume":"79","author":"S Rossner","year":"2006","unstructured":"Rossner S, Sastre M, Bourne K, Lichtenthaler SF (2006) Transcriptional and translational regulation of BACE1 expression\u2014implications for Alzheimer\u2019s disease. Prog Neurobiol 79:95\u2013111","journal-title":"Prog Neurobiol"},{"key":"1765_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jalz.2005.12.001","volume":"2","author":"AD Roses","year":"2006","unstructured":"Roses AD, Saunders AM (2006) Perspective on a pathogenesis and treatment of Alzheimer\u2019s disease. Alzheimers Dement 2:59\u201370","journal-title":"Alzheimers Dement"},{"key":"1765_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","volume":"22","author":"N Guzior","year":"2015","unstructured":"Guzior N, Wieckowska A, Panek D, Malawska B (2015) Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease. Curr Med Chem 22:373\u2013404","journal-title":"Curr Med Chem"},{"key":"1765_CR14","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/jm1003073","volume":"53","author":"M Hieke","year":"2010","unstructured":"Hieke M, Ness J, Steri R, Dittrich M, Greiner C, Werz O, Baumann K, Schubert-Zsilavecz M, Weggen S, Zettl H (2010) Design, synthesis, and biological evaluation of a novel class of \u03b3-secretase modulators with PPAR\u03b3 activity. J Med Chem 53:4691\u20134700","journal-title":"J Med Chem"},{"key":"1765_CR15","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1016\/j.bmc.2011.08.003","volume":"19","author":"M Hieke","year":"2011","unstructured":"Hieke M, Ness J, Steri R, Greiner C, Werz O, Schubert-Zsilavecz M, Weggen S, Zettl H (2011) SAR studies of acidic dual \u03b3-secretase\/PPAR\u03b3 modulators. Bioorg Med Chem 19:5372\u20135382","journal-title":"Bioorg Med Chem"},{"key":"1765_CR16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bmcl.2014.12.073","volume":"25","author":"D Flesch","year":"2015","unstructured":"Flesch D, Ness J, Lamers C, Dehm F, Popella S, Steri R, Ogorek I, Hieke M, Dannhardt G, Werz O, Weggen S, Schubert-Zsilavecz M (2015) SAR-studies of \u03b3-secretase modulators with PPAR\u03b3-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer\u2019s disease. Bioorg Med Chem Lett 25:841\u2013846","journal-title":"Bioorg Med Chem Lett"},{"key":"1765_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JAD-2012-120310","volume":"31","author":"SH Eckert","year":"2012","unstructured":"Eckert SH, Eckmann J, Renner K, Eckert GP, Leuner K, Muller WE (2012) Dimebon ameliorates amyloid-\u03b2 induced impairments of mitochondrial form and function. J Alzheimers Dis 31:21\u201332","journal-title":"J Alzheimers Dis"},{"key":"1765_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JAD-130071","volume":"36","author":"OM Peters","year":"2013","unstructured":"Peters OM, Shelkovnikova T, Tarasova T, Springe S, Kukharsky MS, Smith GA, Brooks S, Kozin SA, Kotelevtsev Y, Bachurin SO, Ninkina N, Buchman VL (2013) Chronic administration of Dimebon does not ameliorate amyloid-\u03b2 pathology in 5xFAD transgenic mice. J Alzheimers Dis 36:589\u2013596","journal-title":"J Alzheimers Dis"},{"key":"1765_CR19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbamem.2009.01.012","volume":"1788","author":"I Peters","year":"2009","unstructured":"Peters I, Igbavboa U, Sch\u00fctt T, Haidari S, Hartig U, Rosello X, B\u00f6ttner S, Copanaki E, Deller T, K\u00f6gel D, Wood WG, M\u00fcller WE, Eckert GP (2009) The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta 1788:964\u2013972","journal-title":"Biochim Biophys Acta"},{"key":"1765_CR20","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","volume":"23","author":"Q Yan","year":"2003","unstructured":"Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters \u03b2-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease. J Neurosci 23:7504\u20137509","journal-title":"J Neurosci"},{"key":"1765_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.11.039","volume":"675","author":"L Chen","year":"2012","unstructured":"Chen L, Lin Z, Zhu Y, Lin N, Zhang J, Pan X, Chen X (2012) Ginsenoside Rg1 attenuates \u03b2-amyloid generation via suppressing PPAR\u03b3-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol 675:15\u201321","journal-title":"Eur J Pharmacol"},{"key":"1765_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"1765_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(93)90011-U","volume":"160","author":"SP Crouch","year":"1993","unstructured":"Crouch SP, Kozlowski R, Slater KJ, Fletcher J (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160:81\u201388","journal-title":"J Immunol Methods"},{"key":"1765_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/CBB:44:2:179","volume":"44","author":"S Stadlmann","year":"2006","unstructured":"Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E (2006) Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1\u03b2-treated human peritoneal mesothelial cells. Cell Biochem Biophys 44:179\u2013186","journal-title":"Cell Biochem Biophys"},{"key":"1765_CR25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/abio.2002.5658","volume":"305","author":"AV Kuznetsov","year":"2002","unstructured":"Kuznetsov AV, Strobl D, Ruttmann E, Konigsrainer A, Margreiter R, Gnaiger E (2002) Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem 305:186\u2013194","journal-title":"Anal Biochem"},{"key":"1765_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arr.2009.04.002","volume":"8","author":"F Mangialasche","year":"2009","unstructured":"Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer\u2019s disease and mild cognitive impairment. Ageing Res Rev 8:285\u2013305","journal-title":"Ageing Res Rev"},{"key":"1765_CR27","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1089\/ars.2006.8.1975","volume":"8","author":"V Calabrese","year":"2006","unstructured":"Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Stella AMG, Butterfield DA (2006) Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer\u2019s disease. Antioxid Redox Signal 8:1975\u20131986","journal-title":"Antioxid Redox Signal"},{"key":"1765_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-2011-110092","volume":"25","author":"E Barone","year":"2011","unstructured":"Barone E, Di Domenico F, Cenini G, Sultana R, Coccia R, Preziosi P, Perluigi M, Mancuso C, Butterfield DA (2011) Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer\u2019s disease and amnestic mild cognitive impairment. J Alzheimer\u2019s Dis 25:623\u2013633","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1765_CR29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/emmm.201200243","volume":"4","author":"FX Guix","year":"2012","unstructured":"Guix FX, Wahle T, Vennekens K, Snellinx A, Ch\u00e1vez-Guti\u00e9rrez L, Ill-Raga G, Ramos-Fernandez E, Guardia-Laguarta C, Lle\u00f3 A, Arimon M, Berezovska O, Mu\u00f1oz FJ, Dotti CG, de Strooper B (2012) Modification of \u03b3-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer\u2019s disease. EMBO Mol Med 4:660\u2013673","journal-title":"EMBO Mol Med"},{"key":"1765_CR30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-132084","volume":"43","author":"S Hagl","year":"2015","unstructured":"Hagl S, Grewal R, Ciobanu I, Helal A, Khayyal MT, Muller WE, Eckert GP (2015) Rice bran extract compensates mitochondrial dysfunction in a cellular model of early Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 43:927\u2013938","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1765_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","volume":"435","author":"MD Brand","year":"2011","unstructured":"Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435:297\u2013312","journal-title":"Biochem J"},{"key":"1765_CR32","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","volume":"590","author":"S Larsen","year":"2012","unstructured":"Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge JW, Dela F, Hey-Mogensen M (2012) Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 590:3349\u20133360","journal-title":"J Physiol"},{"key":"1765_CR33","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","volume":"125","author":"S Austin","year":"2012","unstructured":"Austin S, St-Pierre J (2012) PGC1\u03b1 and mitochondrial metabolism\u2014emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125:4963\u20134971","journal-title":"J Cell Sci"},{"key":"1765_CR34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","volume":"27","author":"C Handschin","year":"2006","unstructured":"Handschin C, Spiegelman BM (2006) Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27:728\u2013735","journal-title":"Endocr Rev"},{"key":"1765_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2011.09.001","volume":"45","author":"L Devi","year":"2012","unstructured":"Devi L, Ohno M (2012) Mitochondrial dysfunction and accumulation of the \u03b2-secretase-cleaved C-terminal fragment of APP in Alzheimer\u2019s disease transgenic mice. Neurobiol Dis 45:417\u2013424","journal-title":"Neurobiol Dis"},{"key":"1765_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada HK, Biswas G, Robin M, Avadhani NG (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41\u201354","journal-title":"J Cell Biol"},{"issue":"Suppl 2","key":"1765_CR37","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","volume":"20","author":"N Dragicevic","year":"2010","unstructured":"Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC (2010) Mitochondrial amyloid-\u03b2 levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer\u2019s transgenic mice. J Alzheimer\u2019s Dis 20(Suppl 2):S535\u2013S550","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1765_CR38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1096\/fj.10-157230","volume":"25","author":"PF Pavlov","year":"2011","unstructured":"Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, Ankarcrona M (2011) Mitochondrial \u03b3-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J 25:78\u201388","journal-title":"FASEB J"},{"key":"1765_CR39","first-page":"417","volume":"102C","author":"M Pellowska","year":"2014","unstructured":"Pellowska M, Stein C, Pohland M, Merk D, Klein J, Eckert GP, Schubert-Zsilavecz M, Wurglics M (2014) Pharmacokinetic properties of MH84, a \u03b3-secretase modulator with PPAR\u03b3 agonistic activity. J Pharm Biomed Anal 102C:417\u2013424","journal-title":"J Pharm Biomed Anal"},{"key":"1765_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang H, Ward WF (2006) PGC-1\u03b1: a key regulator of energy metabolism. Adv Physiol Educ 30:145\u2013151","journal-title":"Adv Physiol Educ"},{"key":"1765_CR41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/acel.12183","volume":"13","author":"A Robinson","year":"2014","unstructured":"Robinson A, Gr\u00f6sgen S, Mett J, Zimmer VC, Haupenthal VJ, Hundsd\u00f6rfer B, Stahlmann CP, Slobodskoy Y, M\u00fcller UC, Hartmann T, Stein R, Grimm MOW (2014) Upregulation of PGC-1\u03b1 expression by Alzheimer\u2019s disease-associated pathway: presenilin 1\/amyloid precursor protein (APP)\/intracellular domain of APP. Aging Cell 13:263\u2013272","journal-title":"Aging Cell"},{"key":"1765_CR42","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1210\/en.2006-0070","volume":"147","author":"E Hondares","year":"2006","unstructured":"Hondares E, Mora O, Yubero P, de la Concepci\u00f3n MR, Iglesias R, Giralt M, Villarroya F (2006) Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1\u03b1 gene transcription: an autoregulatory loop controls PGC-1\u03b1 expression in adipocytes via peroxisome proliferator-activated receptor-\u03b3 coactivation. Endocrinology 147:2829\u20132838","journal-title":"Endocrinology"},{"key":"1765_CR43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1474-9726.2010.00632.x","volume":"9","author":"B Gong","year":"2010","unstructured":"Gong B, Chen F, Pan Y, Arrieta-Cruz I, Yoshida Y, Haroutunian V, Pasinetti GM (2010) SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer\u2019s disease amyloidosis and improves synaptic function. Aging Cell 9:1018\u20131031","journal-title":"Aging Cell"},{"key":"1765_CR44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","volume":"76","author":"HF Dovey","year":"2001","unstructured":"Dovey HF, John V, Anderson JP, Chen LZ, De Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S et al (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76:173\u2013181","journal-title":"J Neurochem"},{"key":"1765_CR45","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/14656560903044982","volume":"10","author":"DB Henley","year":"2009","unstructured":"Henley DB, May PC, Dean RA, Siemers ER (2009) Development of semagacestat (LY450139), a functional \u03b3-secretase inhibitor, for the treatment of Alzheimer\u2019s disease. Expert Opin Pharmacother 10:1657\u20131664","journal-title":"Expert Opin Pharmacother"},{"key":"1765_CR46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ml1000239","volume":"1","author":"KW Gillman","year":"2010","unstructured":"Gillman KW, Starrett JE, Parker MF, Xie K, Bronson JJ, Marcin LR, McElhone KE, Bergstrom CP, Mate RA, Williams R, Meredith JE, Burton CR, Barten DM, Toyn JH, Roberts SB, Lentz KA, Houston JG, Zaczek R, Albright CF, Decicco CP, Macor JE, Olson RE (2010) Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable \u03b3-secretase inhibitor. ACS Med Chem Lett 1:120\u2013124","journal-title":"ACS Med Chem Lett"},{"key":"1765_CR47","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archneurol.2012.2194","volume":"69","author":"V Coric","year":"2012","unstructured":"Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G, Colby S, Rollin L, Dockens R, Pachai C, Portelius E, Andreasson U, Blennow K, Soares H, Albright C, Feldman HH, Berman RM (2012) Safety and tolerability of the \u03b3-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch Neurol 69:1430\u20131440","journal-title":"Arch Neurol"},{"key":"1765_CR48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS, Siemers E, Sethuraman G, Mohs R (2013) A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med 369:341\u2013350","journal-title":"N Engl J Med"},{"key":"1765_CR49","doi-asserted-by":"crossref","first-page":"e0118379","DOI":"10.1371\/journal.pone.0118379","volume":"10","author":"AM Weissmiller","year":"2015","unstructured":"Weissmiller AM, Natera-Naranjo O, Reyna SM, Pearn ML, Zhao X, Nguyen P, Cheng S, Goldstein LSB, Tanzi RE, Wagner SL, Mobley WC, Wu C (2015) A \u03b3-secretase inhibitor, but not a \u03b3-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PloS One 10:e0118379","journal-title":"PloS One"},{"key":"1765_CR50","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","volume":"32","author":"Y Mitani","year":"2012","unstructured":"Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, Ni K, Matsuoka N (2012) Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J Neurosci 32:2037\u20132050","journal-title":"J Neurosci"},{"key":"1765_CR51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH (2001) A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature 414:212\u2013216","journal-title":"Nature"},{"key":"1765_CR52","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.2174\/138161206778793029","volume":"12","author":"S Leuchtenberger","year":"2006","unstructured":"Leuchtenberger S, Beher D, Weggen S (2006) Selective modulation of A\u03b242 production in Alzheimers disease: non-steroidal anti-inflammatory drugs and beyond. CPD 12:4337\u20134355","journal-title":"CPD"},{"key":"1765_CR53","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Ch\u00e1vez-Guti\u00e9rrez","year":"2012","unstructured":"Ch\u00e1vez-Guti\u00e9rrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, van Cleynenbreugel S, Esselmann H, Wiltfang J, Serneels L, Karran E, Gijsen H, Schymkowitz J, Rousseau F, Broersen K, de Strooper B (2012) The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease. EMBO J 31:2261\u20132274","journal-title":"EMBO J"},{"key":"1765_CR54","doi-asserted-by":"crossref","first-page":"31825","DOI":"10.1074\/jbc.M303588200","volume":"278","author":"SA Sagi","year":"2003","unstructured":"Sagi SA, Weggen S, Eriksen J, Golde TE, Koo EH (2003) The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of \u03baB kinase, and NF\u03baB, do not reduce amyloid \u03b242 production. J Biol Chem 278:31825\u201331830","journal-title":"J Biol Chem"},{"key":"1765_CR55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1042\/BJ20050560","volume":"391","author":"C d\u2019Abramo","year":"2005","unstructured":"d\u2019Abramo C, Massone S, Zingg J, Pizzuti A, Marambaud P, Dalla Piccola B, Azzi A, Marinari UM, Pronzato MA, Ricciarelli R (2005) Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death. Biochem J 391:693\u2013698","journal-title":"Biochem J"},{"key":"1765_CR56","doi-asserted-by":"crossref","unstructured":"Cheng H, Shang Y, Jiang L, Shi T, Wang L (2015) The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer\u2019s disease and mild-to-moderate Alzheimer\u2019s disease: a meta-analysis. Int J Neurosci. doi: 10.3109\/00207454.2015.1015722","DOI":"10.3109\/00207454.2015.1015722"},{"key":"1765_CR57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jgs.12722","volume":"62","author":"S Read","year":"2014","unstructured":"Read S, Wu P, Biscow M (2014) Sustained 4-year cognitive and functional response in early Alzheimer\u2019s disease with pioglitazone. J Am Geriatr Soc 62:584\u2013586","journal-title":"J Am Geriatr Soc"},{"key":"1765_CR58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuint.2009.05.001","volume":"55","author":"G Miglio","year":"2009","unstructured":"Miglio G, Rosa AC, Rattazzi L, Collino M, Lombardi G, Fantozzi R (2009) PPAR\u03b3 stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss. Neurochem Int 55:496\u2013504","journal-title":"Neurochem Int"},{"key":"1765_CR59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-130680","volume":"39","author":"S Xu","year":"2014","unstructured":"Xu S, Liu G, Bao X, Wu J, Li S, Zheng B, Anwyl R, Wang Q (2014) Rosiglitazone prevents amyloid-\u03b2 oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number. J Alzheimers Dis 39:239\u2013251","journal-title":"J Alzheimers Dis"},{"key":"1765_CR60","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1523\/JNEUROSCI.4024-13.2014","volume":"34","author":"JB Jahrling","year":"2014","unstructured":"Jahrling JB, Hernandez CM, Denner L, Dineley KT (2014) PPAR\u03b3 recruitment to active ERK during memory consolidation is required for Alzheimer\u2019s disease-related cognitive enhancement. J Neurosci 34:4054\u20134063","journal-title":"J Neurosci"},{"key":"1765_CR61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","volume":"939","author":"S Bachurin","year":"2001","unstructured":"Bachurin S, Bukatina E, Lermontova N, Tkachenko S, Afanasiev A, Grigoriev V, Grigorieva I, Ivanov Y, Sablin S, Zefirov N (2001) Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann N Y Acad Sci 939:425\u2013435","journal-title":"Ann N Y Acad Sci"},{"key":"1765_CR62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1567205011666140505094808","volume":"11","author":"EF Shevtsova","year":"2014","unstructured":"Shevtsova EF, Vinogradova DV, Kireeva EG, Reddy VP, Aliev G, Bachurin SO (2014) Dimebon attenuates the A\u03b2-induced mitochondrial permeabilization. Curr Alzheimer Res 11:422\u2013429","journal-title":"Curr Alzheimer Res"},{"key":"1765_CR63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2010-100174","volume":"21","author":"S Zhang","year":"2010","unstructured":"Zhang S, Hedskog L, Petersen CAH, Winblad B, Ankarcrona M (2010) Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimer\u2019s Dis 21:389\u2013402","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1765_CR64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12017-010-8130-x","volume":"13","author":"KK Naga","year":"2011","unstructured":"Naga KK, Geddes JW (2011) Dimebon inhibits calcium-induced swelling of rat brain mitochondria but does not alter calcium retention or cytochrome C release. Neuromol Med 13:31\u201336","journal-title":"Neuromol Med"},{"key":"1765_CR65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-130872","volume":"38","author":"N Cano-Cuenca","year":"2014","unstructured":"Cano-Cuenca N, del Pozo JESG, Jord\u00e1n J (2014) Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis. J Alzheimer\u2019s Dis 38:155\u2013164","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1765-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1765-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1765-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T02:52:52Z","timestamp":1567479172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1765-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":65,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1765-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}